1,4-Dioxane → HCID 19087650, compound
Reaction equation
[C:1]1([C:7]2[CH2:8][CH2:9][N:10]([CH2:13][CH2:14][CH2:15][CH2:16][NH:17][C:18]3[CH:26]=[CH:25][CH:24]=[C:23]([N+:27]([O-:29])=[O:28])[C:19]=3[C:20]([NH2:22])=[O:21])[CH2:11][CH:12]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[O:30]1CCOC[CH2:31]1>>[C:1]1([C:7]2[CH2:12][CH2:11][N:10]([CH2:13][CH2:14][CH2:15][CH2:16][N:17]3[C:18]4[C:19](=[C:23]([N+:27]([O-:29])=[O:28])[CH:24]=[CH:25][CH:26]=4)[C:20](=[O:21])[NH:22][C:31]3=[O:30])[CH2:9][CH:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Participants
3
Conditions
- Temperature
- 150 °C
Procedure
A mixture of 2-[4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butylamino]-6-nitrobenzamide (300 mg) and N,N'-carbonyldiimidazole (554 mg) in dioxane (3 ml) was stirred for 2 hours at 150° C. The solvent was removed during the reaction. The residue was crystallized from a mixture of ethanol and ether. The crude crystalline materials were collected, washed with methylene chloride, and recrystallized from ethanol to afford 1-[4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl]-5-nitro-2,4(1H,3H)-quinazolinedione (265 mg).
Workup
- customThe solvent was removed during the reaction
- customThe residue was crystallized from a mixture of ethanol and ether
- customThe crude crystalline materials were collected
- washwashed with methylene chloride
- customrecrystallized from ethanol
Sources & evidence
- ORD record
- ord-af334564ed734dd9b56774f7d2e3e007
- Source dataset
- uspto-grants-1994_04
- Patent number
- US05304560
Reaction notes
Loading…